MKManana Dewage Sankani Vishvara Kularathna

Manana Dewage Sankani Vishvara Kularathna

*This is an algorithmically generated author record based on publicly available information.

Manana Dewage Sankani Vishvara Kularathna has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Experience of Therapeutic Plasma Exchange (TPE) in Severe Leptospirosis: A Case Series from Sri Lanka

    by Manana Dewage Sankani Vishvara Kularathna, Senanayake Abeysinghe Mudiyanselage Kularatne

    Background: Leptospirosis is a globally prevalent zoonosis with significant morbidity and mortality, especially in tropical regions like South Asia. In its severe form, the disease often leads to multiorgan dysfunction, with pulmonary haemorrhage being a major cause of death. Evidence supporting specific treatments for severe leptospirosis with pulmonary involvement remains limited. Recent studies suggest that immunomodulatory therapies, such as therapeutic plasma exchange (TPE), may offer survival benefits. This case series explores the application and outcomes of TPE in patients with severe leptospirosis at a tertiary care hospital in Sri Lanka. Methods: We studied a case series involving nine patients with confirmed severe leptospirosis and multiorgan involvement from September 2021 to October 2022. All patients received standard care, including intravenous antibiotics and methylprednisolone. TPE was initiated in all nine patients based on clinical severity, particularly in the presence of pulmonary haemorrhage. Clinical, laboratory, and radiological data were collected from patient records and follow-up. Leptospirosis diagnosis was confirmed through ELISA IgM testing. TPE decisions were made by a multidisciplinary team. Results: Of the nine patients who received TPE, seven survived (78%). Pulmonary haemorrhage was the primary indication for TPE in all cases. All patients had multiorgan involvement: renal failure (89%), hepatic dysfunction (55%), and myocarditis (67%). Mortality was associated with inotropic-dependent myocarditis and mechanical ventilation at TPE initiation. Patients requiring intubation had a 50% mortality rate, compared to 14% in those who were not intubated. Non-survivors also had significantly elevated lactate levels (>4 mmol/L) and worsening acid–base status. Four patients required dialysis: three survived. Conclusions: Early initiation of TPE may be safe and beneficial in severe leptospirosis, and future randomised controlled studies are necessary to examine its benefits further. These findings are hypothesis-generating for further research, particularly on patient selection for TPE.


  • Open Access

    Therapeutic Plasma Exchange (TPE) in Severe Leptospirosis- Application, Factors Affecting Its Life-Saving Benefits and Outcome: A Case Series from Sri Lanka

    by Manana Dewage Sankani Vishvara Kularathna, Senanayake A. M. Kularatne

    Background: Leptospirosis is a globally prevalent zoonosis with significant morbidity and mortality, especially in tropical regions like South Asia. In its severe form, the disease often leads to multiorgan dysfunction, with pulmonary haemorrhage being a significant cause of death. Evidence supporting specific treatments for severe leptospirosis with pulmonary involvement remains limited. Recent studies suggest that immunomodulatory therapies, such as therapeutic plasma exchange (TPE), may offer survival benefits. This case series examines the application and outcomes of TPE in patients with severe leptospirosis at a tertiary-care hospital in Sri Lanka. Methods: We studied a case series involving 10 patients with confirmed severe leptospirosis and multiorgan involvement, from September 2021 to October 2022. All patients received intravenous antibiotics and methylprednisolone. TPE was initiated in nine patients based on clinical severity, particularly in the presence of pulmonary haemorrhage. Clinical, laboratory, and radiological data were collected from patient records and follow-up. ELISA IgM confirmed Leptospirosis. A multidisciplinary team made TPE decisions. Results: Of the nine patients who received TPE, seven survived (77.8%). Pulmonary haemorrhage was the primary indication for TPE in all the cases. All patients had multiorgan involvement: renal failure (90%), hepatic dysfunction (60%), and myocarditis (70%). Mortality was associated with inotropic-dependent myocarditis and mechanical ventilation at TPE initiation. Patients requiring intubation had a 50% mortality rate, compared to 14.3% in those who were not intubated. Non-survivors also had elevated lactate levels (>4 mmol/L) and worsening acid-base status. Four patients required dialysis: three survived. Clinical severity scores increased from admission (mean 3.78) to TPE initiation (mean 4.44), and no patient showed improvement before TPE. Conclusion: Early initiation of TPE may be beneficial in severe leptospirosis, particularly when performed before irreversible cardiopulmonary failure. The combined use of TPE and corticosteroids may provide additional benefit by mitigating immune-mediated tissue injury. These findings support further investigation into the timing and patient selection criteria for TPE in severe leptospirosis, particularly in resource-limited settings.

  • Open Access

    Kikuchi disease complicated with aseptic meningitis following COVID-19 Vaccination: a case report

    by Manana Dewage Sankani Vishvara Kularathna, Arjuna Medagama, Ruwanthi Bandara, Duminda Yasarathna, Madugeta Kumarage Ishara Dilani, Thushani Anuththara

    Background: Kikuchi Fujimoto disease is a rare self-limiting disorder mainly affecting young Asian females. The typical presentation is unexplained fever with associated cervical lymphadenopathy. It can mimic many sinister diseases such as lymphoma, tuberculosis, and systemic lupus erythematosus. Aseptic meningitis due to Kikuchi disease is extremely rare, and majority were reported from Japan. There have been no published cases of aseptic meningitis due to Kikuchi disease in Sri Lanka. Case presentation: A 29 years old Sri Lankan female presented with a prolonged fever for three weeks with an associated headache for five days duration. She developed painful cervical lymphadenopathy during the hospital stay. She has been previously well and had been vaccinated against COVID-19 six weeks before. Her lumbar puncture showed lymphocytic pleocytosis with marginally elevated protein levels and reduced ratio of serum to CSF sugar. Lymph node biopsy was consistent with necrotizing lymphadenitis. She was subsequently diagnosed with Kikuchi disease complicated with aseptic meningitis. She responded to corticosteroids well and had an uneventful recovery. Conclusion: Kikuchi disease is a rare self-limiting disorder that can be complicated with aseptic meningitis on infrequent occasions. Other conditions such as tuberculosis, lymphoma, systemic lupus erythematosus, and adult-onset Still’s disease should be considered as differential diagnoses. Knowledge of Kikuchi disease and its complications will prevent unnecessary investigations which delay the early diagnosis and treatment.


  • Open Access

    Severe leptospirosis complicated with multiorgan dysfunction successfully managed with plasma exchange: a case report

    by Manana Dewage Sankani Vishvara Kularathna, Senanayake Abeysinghe Mudiyanselage Kularatne, Manoji Pathirage, Pala Thanthirige Madhushi Anuradha Nanayakkara

    Background: Leptospirosis is a common zoonotic infection caused by the spirochete Leptospira. The disease is more prevalent in the tropics, causing subclinical to severe illness leading to high morbidity and mortality. Case presentation: A 77-year-old healthy Sri Lankan man presented to the Teaching Hospital Peradeniya with severe leptospirosis complicated with acute kidney injury, pulmonary hemorrhages, myocarditis, and severe thrombocytopenia. He was deteriorating despite treatment with intravenous antibiotics and methylprednisolone boluses. He made a dramatic improvement with two cycles of plasma exchange. Conclusion: Therapeutic plasma exchange is a life-saving treatment modality in severe leptospirosis with multiorgan failure.